A COMPARISON OF THE EFFECTIVENESS AND COST OF TREATMENT FOR VERTEBRAL FRACTURES IN WOMEN

Roger M. Francis(University of Cambridge), David Torgerson(University of York), Frazer H. Anderson

Lara D. Veeken

January 1, 1995

10.1093/rheumatology/34.12.1167

Cited by 102

Related Papers

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women

|Osteoporosis International|2007|1.2k

Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial

|The Lancet|2005|976

CONSORT 2025 statement: updated guideline for reporting randomised trials

|BMJ|2025|847

Guidelines for diagnosis and management of osteoporosis

|Osteoporosis International|1997|793

Understanding controlled trials: What are pragmatic trials?

|BMJ|1998|721